APA (7th ed.) Citation

C, S., S, M., S, F., M, D., R, M., F, C., . . . SA, G. (2024). G6pdN126D Variant Increases the Risk of Developing VEGFR (Vascular Endothelial Growth Factor Receptor) Blocker-Induced Pulmonary Vascular Disease. Journal of the American Heart Association, 13(19), e035174. https://doi.org/10.1161/JAHA.123.035174

Chicago Style (17th ed.) Citation

C, Signoretti, et al. "G6pdN126D Variant Increases the Risk of Developing VEGFR (Vascular Endothelial Growth Factor Receptor) Blocker-Induced Pulmonary Vascular Disease." Journal of the American Heart Association 13, no. 19 (2024): e035174. https://doi.org/10.1161/JAHA.123.035174.

MLA (9th ed.) Citation

C, Signoretti, et al. "G6pdN126D Variant Increases the Risk of Developing VEGFR (Vascular Endothelial Growth Factor Receptor) Blocker-Induced Pulmonary Vascular Disease." Journal of the American Heart Association, vol. 13, no. 19, 2024, p. e035174, https://doi.org/10.1161/JAHA.123.035174.